أوكسي فيت-فارما 3% محلول للحقن
Oxyvet-Pharma 3% Injectable Solution contains Oxytetracycline (as HCl) 30 mg/ml for the treatment of systemic bacterial and rickettsial infections in cattle, sheep, goats, horses, dogs, and cats.
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cattle | 1 – 5 ml / 15 kg body weight | intramuscular or intravenous | 3 – 5 days |
| Sheep | 1 – 5 ml / 15 kg body weight | intramuscular or intravenous | 3 – 5 days |
| Goat | 1 – 5 ml / 15 kg body weight | intramuscular or intravenous | 3 – 5 days |
| Horse | 1 – 5 ml / 15 kg body weight | intravenous | 3 – 5 days |
| Dog | 1 – 5 ml / 15 kg body weight | intramuscular or intravenous | 3 – 5 days |
| Cat | 1 – 5 ml / 15 kg body weight | intramuscular or intravenous | 3 – 5 days |
| Species | Meat (days) | Milk (days) | Eggs (days) |
|---|---|---|---|
| Cattle | 35 | 6 | |
| Sheep | 14 |
Shipping fever pneumonia caused by Pasteurella multocida, Mannheimia haemolytica and Mycoplasma bovis in cattle; Anaplasmosis caused by Anaplasma marginale in cattle; Theileriosis caused by Theileria parva in cattle; Listeriosis caused by Listeria monocytogenes in ruminants; Pneumonia caused by Pasteurella haemolytica in sheep and goats; Control of enzootic abortion in sheep caused by Chlamydia abortus; Chlamydial conjunctivitis caused by Chlamydia spp. in dogs and cats; Ehrlichiosis caused by Neorickettsia (Ehrlichia) risticii in horses.
Not to be used in animals with hypersensitivity to tetracyclines.
Avoid subcutaneous injection or concurrent corticosteroids in horses.
Not to be used in sheep producing milk for human consumption.
Not to be used before last half of pregnancy.
Administered with extreme caution in pregnancy, and to be used only in the last half of pregnancy.
Oxytetracycline used cautiously in animals with renal or hepatic impairment, and to be used lower than normal doses with monitoring of renal and hepatic function.
Avoid subcutaneous injection or concurrent corticosteroids in horses.
May cause vomiting and diarrhea.
Photodermatitis.
Transient swelling at site of injection.
Official Pharma Swede Product Specification
Datasheet30 mg/ml
Manufacturer
No alternatives available.